Next report date
Report period
Q1 2024
EPS estimate
−0.49USD
Revenue estimate
16.32 MUSD
−2.07USD
−46.66 MUSD
58.45 MUSD
17.01 M
About TELA Bio, Inc.
Sector
Industry
CEO
Antony Koblish
Website
Headquarters
Malvern
Employees (FY)
227
Founded
2012
FIGI
BBG004CH7Z50
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TELA is 4.45 USD — it has increased by 1.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TELA Bio, Inc. stocks are traded under the ticker TELA.
TELA Bio, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
TELA stock is 2.63% volatile and has beta coefficient of 0.74. Check out the list of the most volatile stocks — is TELA Bio, Inc. there?
TELA earnings for the last quarter are −0.45 USD per share, whereas the estimation was −0.48 USD resulting in a 6.42% surprise. The estimated earnings for the next quarter are −0.45 USD per share. See more details about TELA Bio, Inc. earnings.
TELA Bio, Inc. revenue for the last quarter amounts to 15.05 M USD despite the estimated figure of 16.20 M USD. In the next quarter revenue is expected to reach 16.46 M USD.
Yes, you can track TELA Bio, Inc. financials in yearly and quarterly reports right on TradingView.
TELA stock has fallen by 13.26% compared to the previous week, the month change is a 18.35% fall, over the last year TELA Bio, Inc. has showed a 53.01% decrease.
TELA net income for the last quarter is −12.89 M USD, while the quarter before that showed −10.96 M USD of net income which accounts for −17.64% change. Track more TELA Bio, Inc. financial stats to get the full picture.
Today TELA Bio, Inc. has the market capitalization of 108.23 M, it has decreased by 8.03% over the last week.
No, TELA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TELA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TELA Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 227.00 employees. See our rating of the largest employees — is TELA Bio, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TELA Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TELA Bio, Inc. stock shows the strong sell signal. See more of TELA Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TELA Bio, Inc. future price: according to them, TELA price has a max estimate of 18.00 USD and a min estimate of 12.00 USD. Read a more detailed TELA Bio, Inc. forecast: see what analysts think of TELA Bio, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TELA Bio, Inc. EBITDA is −43.27 M USD, and current EBITDA margin is −74.02%. See more stats in TELA Bio, Inc. financial statements.